Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

‘Like copying a Louis Vuitton handbag’: big pharma hits out at Africa’s replica Covid vaccine

Knowledge-sharing hub in Cape Town reverse engineered the Moderna vaccine, but future of the initiative to reduce inequity remains unsure

The Guardian - UK

Coronavirus (booster) FAQ: Can it cause a positive test? When should you get it?

There is a lot of information about coronavirus vaccines out there, and some of it seems vague or contradictory. We talked to experts to help answer some of the most common and confusing questions.

WEKU

Panel rejects $1M payouts to inmates given vaccine overdoses

A state board has rejected claims for $1 million payments for 52 prison inmates who were given six times the proper dose of COVID-19 vaccines last year

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Myovant Sciences Rejects $2.5 Billion Takeover. Now What?

The women's health drug specialist rebuffed an offer from its majority shareholder. A roller coaster ride could be ahead.

The Street

Myovant Sciences Rockets After Rejecting Lowball Sumitovant Biopharma Takeover Bid

Myovant Sciences turned down a takeover bid from majority shareholder Sumitovant Biopharma on Monday, and MYOV stock skyrocketed.

Investors Business Daily

What Are Whales Doing With Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 11 strange trades.

Benzinga

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Woman left with 'debilitating' lesions and unable to eat for months after Covid jab

Doctors struggled to diagnose the root of the cause due to lack of reporting, after an Australian woman suffered from "debilitating" lesions on her tongue after receiving a Pfizer Covid vaccine

Daily Mirror

All the latest COVID news and case numbers from around the states and territories

Here's a quick wrap of the latest COVID-19 news and case numbers from each Australian jurisdiction from the past week.

ABC News

Doctor's warning on axing isolation rules

The head of the AMA has blasted state and territory leaders advocating for scrapping COVID isolation requirements, saying they're putting lives at risk.

AAP

Pfizer COVID vaccine approved for all children aged over six months old

The Therapeutic Goods Administration approves Pfizer's paediatric dose of its COVID vaccine for children aged between six months and five years old.

ABC News

Interim tick for Pfizer infant booster

The Therapeutic Goods Administration has given provisional approval for Pfizer's COVID-19 booster to be used in children aged six months to five years.

AAP

Pfizer pays $179m for Brisbane company behind smartphone app that claims to diagnose COVID

Recent studies had shown the app had a 92 per cent success rate in diagnosing the virus among symptomatic patients, but more clinical trials were needed for it to gain regulatory approval.

ABC News

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Bloomberg

Salon

No, AI won't change Big Pharma

Claims that artificial intelligence will change the way drugs are made are almost certainly overblown. Here’s why

WEKU

State Health Commissioner urges Kentuckians to keep getting Covid-19 vaccine

State health officials continue to urge Kentuckians to get vaccinated against COVID-19. New boosters are available to help deal with the newer strains of the illness.

Los Angeles Times

Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots?

LOS ANGELES — As residents prepare to roll up their sleeves for a third, fourth or even fifth dose of COVID-19 vaccine, some may be wondering: Do I need to stick with the same brand, or is it safe to mix it up?

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

IBD Stock Of The Day: Could 'The Biggest Drug Ever' Drive Eli Lilly Stock Even Higher?

Eli Lilly is the IBD Stock Of The Day as investors watch the company's obesity and Alzheimer's drugs, which could help shares skyrocket.

Reuters

U.S. cutting global donations of Pfizer COVID shots as demand slows

The United States is significantly cutting back the number of Pfizer/BioNTech COVID-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries.

Tribune News Service

Pfizer, US revise contract for donated vaccines as world demand plummets

WASHINGTON — President Joe Biden’s administration has slashed its target for COVID-19 vaccine donations abroad this year, amending a contract with Pfizer Inc. in the latest sign that world demand for the shots has collapsed.

Investors Business Daily

The 'Transformative' Eli Lilly Drug That Could Top $25 Billion In Annual Sales

Eli Lilly's blockbuster potential diabetes drug Mounjaro is "de-risked and transformative," an analyst said Thursday as he updated LLY stock.

The Independent UK

Israel rolls out new omicron-tailored COVID-19 vaccines

Israel has started administering doses of the new COVID-19 vaccine tailored to fight the highly infectious omicron variant

The Street

Novavax Stock Slides As JPMorgan Slashes Price Target, Lowers Rating

JPMorgan analyst Eric Joseph slashed his price target on Novavax by more than $100, to $27 per share.

The Guardian - US

Covid vaccination rates in US children under five lag despite effectiveness

Biden’s recent announcement that the pandemic is ending could slow process further, as parents question the necessity of shots

1 … 31 32 33 34

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.